Are you a robotics manufacturer?
Claim your page to correct your specs and keep your listing current.
Marsi Bionics is a robotics company founded 2013, based in Spain, developing 3 robots primarily in the Exoskeleton category.
CAPITAL & EVIDENCE
Shipped
No deployment evidence on file
A deployment is recorded when a public source names both the customer and the robot, or the maker confirms it. Nothing here counts against Marsi Bionics.
In Exoskeleton, exoIQ, ExoAtlet and Hyundai Motor Group have deployment evidence on file.
Add a deployment →Robotic gait and exoskeleton systems for rehabilitation and mobility
Marsi Bionics develops robotic gait and exoskeleton systems, including the MAK Active Knee for gait rehabilitation, the EXPLORER MB pediatric exoskeleton, and the ATLAS pediatric exo/ATLAS 2030 platform. Its devices are aimed at clinical rehabilitation and mobility support for patients with knee weakness, hemiplegia, cerebral palsy, and spinal muscular atrophy, with use cases in Spain and other clinical settings.
Active products
3
RoboIndex
47.30
RoboScore 47.30 + Momentum 0.00
Company facts
- HQ
- Rivas-Vaciamadrid, Spain
- Founded
- 2013 · 13 yrs
- Website
- marsibionics.com
RoboScore
47.30 RoboScore + 0.00 Momentum· Adequate evidence
Products 65%, Depth 5%, Evidence 30% set the number, and every rated company has all three. Attention has no weight of its own — it is one of the two things Evidence is built from, and it can only ever add. Activity and Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.
4 of 6 factors known. How it's calculated
Milestones
A clinical study reported safety and usability of the ATLAS 2030 pediatric robotic gait device in children with cerebral palsy and spinal muscular atrophy.
Marsi Bionics was founded in Spain.
Press coverage
- Marsi Bionics - Exo Guide
Exo Guide
- Usability and Safety of the ATLAS 2030 Robotic Gait Device in Children with Cerebral Palsy and Spinal Muscular Atrophy
PubMed Central
- Marsi Bionics | The most innovative technology | Enabling human gait
Marsi Bionics
- EXPLORER MB: A new life to be discovered - Marsi Bionics
Marsi Bionics
Public loss record
Consumer product alerts from this country reach the EU Safety Gate, which we read. Industrial, workplace and medical incidents never enter it, so a blank record says nothing about those.
Active products by Marsi Bionics
3 shown| # | Category | ||||
|---|---|---|---|---|---|
| 1 |  | MAK ACTIVE KNEE | Exoskeleton | 2020 | 51.8 |
| 2 |  | ATLAS PEDIATRIC EXO | Exoskeleton | 2026 | 48.7 |
| 3 |  | EXPLORER MB | Exoskeleton | 2025 | 48.0 |
Exoskeleton buying guides
Industry Knowledge →
The exoskeleton vendor RFP: questions and red flags
Most exoskeleton RFPs focus on spec sheets. The questions that protect you are about fit programs, hygiene, evidence, regulatory clearance, and what happens whe…
A 90-day deployment playbook for industrial exoskeleton programs
A 90-day structured deployment — with ergonomics baseline, task selection, worker fit, hygiene protocol, and measurement — is what separates programs that scale…
Exoskeleton decision framework: passive vs. powered, industrial vs. medical
The exoskeleton market spans four device architectures, two primary buyer types, and dozens of body-region configurations. This framework maps the decision tree…